Pharmadrug Statistics

Total Valuation

Pharmadrug has a market cap or net worth of CAD 1.08 million. The enterprise value is 2.53 million.

Market Cap	1.08M
Enterprise Value	2.53M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmadrug has 108.23 million shares outstanding. The number of shares has increased by 58.70% in one year.

Current Share Class	108.23M
Shares Outstanding	108.23M
Shares Change (YoY)	+58.70%
Shares Change (QoQ)	+4.33%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	n/a
Float	108.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-0.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.38
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-17.62%
Return on Invested Capital (ROIC)	-135.05%
Return on Capital Employed (ROCE)	17.65%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.00% in the last 52 weeks. The beta is 1.62, so Pharmadrug's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-40.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	77.37
Average Volume (20 Days)	381,779

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-236,425
Pretax Income	-449,086
Net Income	-396,385
EBITDA	-186,181
EBIT	-236,425
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 74,772 in cash and 1.38 million in debt, giving a net cash position of -1.30 million or -0.01 per share.

Cash & Cash Equivalents	74,772
Total Debt	1.38M
Net Cash	-1.30M
Net Cash Per Share	-0.01
Equity (Book Value)	-1.34M
Book Value Per Share	-0.01
Working Capital	-1.89M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-227,764
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharmadrug does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.70%
Shareholder Yield	n/a
Earnings Yield	-36.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.1428571.

Last Split Date	Oct 24, 2023
Split Type	Reverse
Split Ratio	0.1428571

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a